Free Trial

CME Group (CME) Financials

CME Group logo
$285.98 +1.62 (+0.57%)
Closing price 05/28/2025 04:00 PM Eastern
Extended Trading
$285.38 -0.61 (-0.21%)
As of 05/28/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for CME Group

Annual Income Statements for CME Group

This table shows CME Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders
3,482 3,186 2,657 2,617 2,105 4,233 1,961 4,063 1,534 1,247
Consolidated Net Income / (Loss)
3,526 3,226 2,691 2,637 2,106 4,232 1,962 4,063 1,534 1,247
Net Income / (Loss) Continuing Operations
3,526 3,226 2,691 2,637 2,106 4,232 1,964 4,063 1,534 1,247
Total Pre-Tax Income
4,541 4,154 3,490 3,374 2,722 2,690 2,778 2,526 2,288 1,957
Total Operating Income
3,932 3,436 3,016 2,645 2,637 2,588 2,608 2,311 2,201 1,989
Total Gross Profit
5,280 4,750 4,266 3,853 4,027 3,969 3,520 3,081 3,052 2,649
Total Revenue
6,130 5,579 5,019 4,690 4,884 4,868 4,309 3,645 3,595 3,327
Operating Revenue
6,130 5,579 5,019 4,690 4,884 4,868 4,309 3,645 3,595 3,269
Total Cost of Revenue
850 829 753 837 857 899 789 564 543 678
Operating Cost of Revenue
850 829 753 837 857 899 789 564 543 678
Total Operating Expenses
1,348 1,315 1,250 1,208 1,390 1,382 912 770 852 661
Selling, General & Admin Expense
400 421 379 393 482 535 493 314 393 247
Depreciation Expense
115 126 135 148 153 159 119 113 129 129
Amortization Expense
222 227 228 238 311 315 130 96 96 99
Other Operating Expenses / (Income)
611 542 509 430 443 374 171 248 233 185
Total Other Income / (Expense), net
610 718 474 728 85 102 170 216 87 -32
Interest Expense
161 159 163 167 166 178 158 117 124 117
Interest & Investment Income
4,430 5,572 2,500 553 373 815 898 661 252 130
Other Income / (Expense), net
-3,659 -4,695 -1,862 343 -122 -535 -570 -328 -41 -45
Income Tax Expense
1,016 927 799 737 616 574 814 -1,537 754 710
Basic Earnings per Share
$9.69 $8.87 $7.41 $7.30 $5.88 $5.93 $5.73 $12.00 $4.55 $3.71
Weighted Average Basic Shares Outstanding
359.39M 359.02M 358.71M 358.34M 357.76M 357.16M 342.34M 338.71M 337.50M 336.22M
Diluted Earnings per Share
$9.67 $8.86 $7.40 $7.29 $5.87 $5.91 $5.71 $11.94 $4.53 $3.69
Weighted Average Diluted Shares Outstanding
359.94M 359.50M 359.18M 358.93M 358.52M 358.24M 343.74M 340.23M 338.97M 337.89M
Weighted Average Basic & Diluted Shares Outstanding
360.36M 359.99M 359.72M 359.40M 359.01M 357.16M 342.34M 340.39M 339.65M 338.42M
Cash Dividends to Common per Share
$10.40 - - $6.85 $5.90 $5.50 $4.55 $6.14 $5.65 $4.90

Quarterly Income Statements for CME Group

This table shows CME Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
956 830 913 883 855 774 750 778 884 604 680
Consolidated Net Income / (Loss)
956 875 913 883 855 815 750 778 884 638 680
Net Income / (Loss) Continuing Operations
956 875 913 883 855 815 750 778 884 638 680
Total Pre-Tax Income
1,245 1,097 1,177 1,155 1,113 1,006 974 1,016 1,157 827 880
Total Operating Income
1,108 947 1,024 1,001 960 863 820 839 914 668 739
Total Gross Profit
1,436 1,305 1,366 1,328 1,282 1,226 1,132 1,155 1,237 1,015 1,038
Total Revenue
1,642 1,525 1,584 1,533 1,488 1,439 1,338 1,360 1,442 1,208 1,228
Operating Revenue
1,642 1,525 1,584 1,533 1,488 1,439 1,338 1,360 1,442 1,208 1,228
Total Cost of Revenue
207 221 219 205 206 213 206 206 205 193 190
Operating Cost of Revenue
207 221 219 205 206 213 206 206 205 193 190
Total Operating Expenses
328 357 341 327 322 363 312 316 323 347 299
Selling, General & Admin Expense
83 124 93 93 90 138 89 95 99 134 79
Depreciation Expense
27 28 28 29 30 31 31 32 32 34 35
Amortization Expense
55 55 56 56 55 56 57 57 57 57 56
Other Operating Expenses / (Income)
162 150 164 150 147 139 135 132 136 122 130
Total Other Income / (Expense), net
137 150 153 154 154 143 154 178 243 159 141
Interest Expense
42 41 40 40 40 40 40 40 40 40 40
Interest & Investment Income
981 1,028 1,113 1,131 1,159 1,144 1,349 1,643 1,436 1,216 763
Other Income / (Expense), net
-802 -838 -920 -937 -965 -961 -1,156 -1,425 -1,153 -1,017 -581
Income Tax Expense
289 222 264 271 258 191 224 239 273 189 200
Basic Earnings per Share
$2.63 $2.40 $2.51 $2.43 $2.35 $2.24 $2.06 $2.14 $2.43 $1.76 $1.87
Weighted Average Basic Shares Outstanding
359.61M 359.39M 359.40M 359.33M 359.26M 359.02M 359.02M 358.94M 358.93M 358.71M 358.72M
Diluted Earnings per Share
$2.62 $2.40 $2.50 $2.42 $2.35 $2.23 $2.06 $2.14 $2.43 $1.76 $1.87
Weighted Average Diluted Shares Outstanding
360.23M 359.94M 359.99M 359.87M 359.83M 359.50M 359.62M 359.43M 359.31M 359.18M 359.29M
Weighted Average Basic & Diluted Shares Outstanding
360.36M 360.36M 360.36M 720.19M 720.13M 359.99M 719.99M 719.50M 359.72M 359.72M 359.73M
Cash Dividends to Common per Share
$1.25 - $1.15 $1.15 $1.15 - $1.10 $1.10 $1.10 - $1.00

Annual Cash Flow Statements for CME Group

This table details how cash moves in and out of CME Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents
8,684 -44,865 -22,816 72,370 49,787 -2,199 -529 -54 165 327
Net Cash From Operating Activities
3,691 3,454 3,056 2,402 2,716 2,673 2,441 -1,751 1,732 1,533
Net Cash From Continuing Operating Activities
3,691 3,454 3,056 2,402 2,716 2,673 2,441 1,751 1,732 1,524
Net Income / (Loss) Continuing Operations
3,526 3,226 2,691 2,637 2,106 2,116 1,964 4,063 1,534 1,247
Consolidated Net Income / (Loss)
3,526 3,226 2,691 2,637 2,106 2,116 1,964 4,063 1,534 1,247
Depreciation Expense
115 126 135 148 153 159 119 113 129 129
Amortization Expense
222 227 228 238 311 315 130 96 96 99
Non-Cash Adjustments To Reconcile Net Income
83 -64 56 -438 129 104 10 -2,415 43 189
Changes in Operating Assets and Liabilities, net
-255 -61 -54 -182 16 -21 226 -105 -70 -132
Net Cash From Investing Activities
-83 21 -490 58 -176 -153 -1,890 180 54 18
Net Cash From Continuing Investing Activities
-83 21 -490 58 -176 -153 -1,890 180 54 18
Purchase of Property, Plant & Equipment
-94 -76 -90 -127 -198 -246 -117 -82 -92 -114
Acquisitions
0.00 0.00 -410 -53 0.00 0.00 -1,795 0.00 0.00 -
Purchase of Investments
-8.10 -6.50 -7.50 -12 -17 -15 -10 -8.30 -55 -45
Sale and/or Maturity of Investments
20 104 17 111 39 108 12 2.50 192 177
Net Cash From Financing Activities
5,077 -48,339 -25,382 69,909 47,247 -4,719 -1,080 -1,985 -1,621 -1,224
Net Cash From Continuing Financing Activities
5,077 -48,339 -25,382 69,909 47,247 -4,719 -1,080 -1,985 -1,621 -1,224
Repayment of Debt
-9.20 -26 -764 -3.10 -2.20 -624 -437 40 2.20 -671
Payment of Dividends
-3,584 -3,236 -2,634 -2,189 -2,110 -1,696 -2,150 -1,994 -1,787 -1,343
Issuance of Debt
0.00 0.00 741 0.00 -305 - 387 0.00 0.00 744
Other Financing Activities, net
8,670 -45,078 -22,725 71,136 49,663 -2,399 -65 -31 165 47
Cash Interest Paid
130 130 133 133 133 146 108 85 85 89
Cash Income Taxes Paid
1,198 1,109 973 755 653 591 577 763 707 717

Quarterly Cash Flow Statements for CME Group

This table details how cash moves in and out of CME Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
20,312 8.50 14,321 -8,451 2,806 3,612 -25,630 -14,534 -8,313 -4,135 1,795
Net Cash From Operating Activities
1,117 1,018 1,003 777 893 1,044 857 650 902 982 658
Net Cash From Continuing Operating Activities
1,117 1,018 1,003 777 893 1,044 857 650 902 982 658
Net Income / (Loss) Continuing Operations
956 875 913 883 855 815 750 778 884 638 680
Consolidated Net Income / (Loss)
956 875 913 883 855 815 750 778 884 638 680
Depreciation Expense
27 28 28 29 30 31 31 32 32 34 35
Amortization Expense
55 55 56 56 55 56 57 57 57 57 56
Non-Cash Adjustments To Reconcile Net Income
24 38 30 -8.50 24 -73 37 10 -39 2.60 12
Changes in Operating Assets and Liabilities, net
54 22 -23 -182 -72 216 -19 -227 -31 250 -124
Net Cash From Investing Activities
-16 -25 -30 -5.00 -23 -20 -20 78 -17 -26 -24
Net Cash From Continuing Investing Activities
-16 -25 -30 -5.00 -23 -20 -20 78 -17 -26 -24
Purchase of Property, Plant & Equipment
-14 -26 -30 -18 -20 -21 -20 -21 -15 -24 -24
Purchase of Investments
-5.40 -0.20 -1.30 -1.90 -4.70 -1.10 -0.40 -2.30 -2.70 -2.70 -0.80
Sale and/or Maturity of Investments
3.60 1.10 1.60 15 1.70 1.50 0.80 101 0.70 1.40 1.20
Net Cash From Financing Activities
19,211 -984 13,347 -9,223 1,936 2,589 -26,467 -15,263 -9,199 -5,091 1,161
Net Cash From Continuing Financing Activities
19,211 -984 13,347 -9,223 1,936 2,589 -26,467 -15,263 -9,199 -5,091 1,161
Repayment of Debt
-754 -0.20 -4.40 -0.30 -4.30 -8.90 - -13 -4.10 1.00 -4.30
Payment of Dividends
-2,567 -419 -419 -419 -2,328 -400 -400 -400 -2,036 -364 -363
Issuance of Debt
742 - - - - - - - - - -
Other Financing Activities, net
21,791 -565 13,770 -8,804 4,269 2,998 -26,067 -14,850 -7,159 -4,729 1,528
Cash Interest Paid
41 24 41 24 41 24 41 24 41 25 41
Cash Income Taxes Paid
13 259 289 535 115 226 272 581 31 169 325

Annual Balance Sheets for CME Group

This table presents CME Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets
137,447 129,706 174,176 196,780 124,660 75,215 77,476 75,791 69,369 67,359
Total Current Assets
103,034 94,890 139,078 161,762 89,284 39,568 41,887 46,907 40,032 37,905
Cash & Equivalents
2,892 2,912 2,720 2,835 1,633 1,551 1,375 1,904 1,869 1,693
Short-Term Investments
113 112 96 115 101 83 73 90 83 73
Accounts Receivable
573 536 483 435 461 492 553 360 364 358
Other Current Assets
99,455 91,331 135,779 158,377 87,089 37,441 39,886 44,553 37,715 35,782
Plant, Property, & Equipment, net
386 410 456 505 579 544 449 400 425 492
Total Noncurrent Assets
34,027 34,406 34,642 34,513 34,797 35,104 35,140 28,485 28,913 28,963
Goodwill
10,487 10,495 10,483 10,528 10,799 10,743 10,805 7,569 7,569 7,569
Intangible Assets
19,997 20,226 20,445 20,707 17,175 22,293 22,675 19,522 19,617 19,713
Other Noncurrent Operating Assets
3,544 3,686 3,714 3,278 1,957 2,068 1,660 1,394 1,727 1,681
Total Liabilities & Shareholders' Equity
137,447 129,706 174,176 196,780 124,660 75,215 77,476 75,791 69,369 67,359
Total Liabilities
110,960 102,968 147,297 169,381 98,308 49,056 51,510 53,379 49,029 46,808
Total Current Liabilities
102,314 93,417 137,688 160,398 88,198 38,523 41,273 45,673 38,946 36,825
Short-Term Debt
750 0.00 16 749 0.00 - 574 0.00 - -
Accounts Payable
80 91 121 49 69 62 116 31 26 29
Other Current Liabilities
101,484 93,326 137,550 159,600 88,129 38,461 40,582 45,642 38,919 36,796
Total Noncurrent Liabilities
8,646 9,551 9,610 8,983 10,110 10,534 10,238 7,707 10,083 9,983
Long-Term Debt
2,678 3,425 3,422 2,696 3,444 3,743 3,827 2,233 2,231 2,229
Noncurrent Deferred & Payable Income Tax Liabilities
5,247 5,328 5,361 5,390 5,607 5,635 5,666 4,858 7,291 7,358
Other Noncurrent Operating Liabilities
721 798 826 897 1,059 1,155 745 616 561 396
Total Equity & Noncontrolling Interests
26,487 26,738 26,879 27,399 26,352 26,159 25,965 22,412 20,341 20,552
Total Preferred & Common Equity
26,487 26,738 26,879 27,399 26,320 26,129 25,919 22,412 20,341 20,552
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
26,487 26,738 26,879 27,399 26,320 26,129 25,919 22,412 20,341 20,552
Common Stock
22,407 22,338 22,265 22,194 21,189 21,117 21,058 17,900 17,830 17,725
Retained Earnings
4,186 4,455 4,747 5,152 4,996 5,009 4,855 4,497 2,525 2,908
Accumulated Other Comprehensive Income / (Loss)
-106 -56 -133 54 135 3.40 5.30 14 -14 -81

Quarterly Balance Sheets for CME Group

This table presents CME Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Total Assets
157,832 137,447 137,795 123,379 132,054 129,706 125,598 151,297 166,039 174,176 178,432
Total Current Assets
123,445 103,034 103,143 88,749 97,308 94,890 90,777 116,366 131,032 139,078 143,253
Cash & Equivalents
1,405 2,892 2,322 1,790 1,437 2,912 2,300 1,880 1,565 2,720 2,130
Short-Term Investments
114 113 112 122 121 112 104 107 105 96 91
Accounts Receivable
770 573 629 600 628 536 558 599 724 483 580
Other Current Assets
121,156 99,455 100,079 86,238 95,122 91,331 87,814 113,780 128,638 135,779 140,451
Plant, Property, & Equipment, net
371 386 386 385 396 410 417 430 440 456 466
Total Noncurrent Assets
34,015 34,027 34,266 34,246 34,350 34,406 34,404 34,501 34,567 34,642 34,713
Goodwill
10,500 10,487 10,514 10,489 10,490 10,495 10,478 10,491 10,491 10,483 10,447
Intangible Assets
19,949 19,997 20,068 20,108 20,165 20,226 20,271 20,336 20,393 20,445 20,478
Other Noncurrent Operating Assets
3,567 3,544 3,685 3,650 3,695 3,686 3,656 3,674 3,684 3,714 3,788
Total Liabilities & Shareholders' Equity
157,832 137,447 137,795 123,379 132,054 129,706 125,598 151,297 166,039 174,176 178,432
Total Liabilities
130,801 110,960 109,579 95,744 104,900 102,968 97,447 123,479 138,655 147,297 150,181
Total Current Liabilities
121,420 102,314 100,822 86,974 96,101 93,417 87,881 113,886 129,044 137,688 140,573
Short-Term Debt
0.00 750 750 750 749 0.00 0.00 0.00 16 16 15
Accounts Payable
100 80 130 100 111 91 54 51 97 121 95
Other Current Liabilities
121,320 101,484 99,942 86,125 95,241 93,326 87,827 113,835 128,930 137,550 140,463
Total Noncurrent Liabilities
9,381 8,646 8,757 8,770 8,798 9,551 9,566 9,593 9,611 9,610 9,608
Long-Term Debt
3,419 2,678 2,678 2,677 2,677 3,425 3,425 3,424 3,423 3,422 3,422
Noncurrent Deferred & Payable Income Tax Liabilities
5,240 5,247 5,310 5,309 5,317 5,328 5,333 5,344 5,357 5,361 5,352
Other Noncurrent Operating Liabilities
721 721 769 783 804 798 809 826 831 826 835
Total Equity & Noncontrolling Interests
27,031 26,487 28,216 27,636 27,154 26,738 28,152 27,818 27,384 26,879 28,251
Total Preferred & Common Equity
27,031 26,487 28,216 27,636 27,154 26,738 28,152 27,818 27,384 26,879 28,251
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
27,031 26,487 28,216 27,636 27,154 26,738 28,152 27,818 27,384 26,879 28,251
Common Stock
22,420 22,407 22,379 22,376 22,349 22,338 22,313 22,311 22,285 22,265 22,239
Retained Earnings
4,686 4,186 5,848 5,355 4,891 4,455 5,956 5,607 5,230 4,747 6,112
Accumulated Other Comprehensive Income / (Loss)
-75 -106 -11 -95 -86 -56 -117 -100 -131 -133 -100

Annual Metrics And Ratios for CME Group

This table displays calculated financial ratios and metrics derived from CME Group's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
9.88% 11.15% 7.03% -3.97% 0.32% 12.96% 18.24% 1.38% 8.07% 6.89%
EBITDA Growth
167.19% -159.80% -55.05% 13.22% 17.94% 10.49% 4.35% -8.12% 9.74% 8.45%
EBIT Growth
121.62% -209.16% -61.39% 18.80% 22.51% 0.75% 2.78% -8.18% 11.06% 9.82%
NOPAT Growth
14.38% 14.77% 12.46% 1.31% 0.25% 10.43% -50.40% 151.85% 16.44% 12.65%
Net Income Growth
9.29% 19.89% 2.05% 25.19% -50.22% 115.66% -51.71% 164.87% 23.02% 10.66%
EPS Growth
9.14% 19.73% 1.51% 24.19% -0.68% 3.50% -52.18% 163.58% 22.76% 10.15%
Operating Cash Flow Growth
6.85% 13.02% 27.21% -11.53% 1.60% 9.51% 239.39% -201.10% 13.02% 18.67%
Free Cash Flow Firm Growth
8.34% 11.45% 203.33% -136.99% 164.74% 160.73% -362.53% -9.96% 1.62% 81.67%
Invested Capital Growth
-0.85% -1.31% -1.41% 20.26% -17.94% -2.25% 27.67% 9.85% -1.88% -2.66%
Revenue Q/Q Growth
1.42% 4.33% 1.22% 1.05% -0.81% -1.98% 8.47% -0.35% 2.83% -0.81%
EBITDA Q/Q Growth
50.62% 21.39% -41.12% 5.67% 1.00% 0.11% 4.82% -4.49% 2.58% -0.11%
EBIT Q/Q Growth
320.87% 16.62% -47.77% 7.44% 1.00% -1.04% 3.29% -4.66% 2.78% -0.12%
NOPAT Q/Q Growth
1.88% 7.33% 0.89% 4.35% -1.03% 2.77% -56.11% 173.29% 3.01% -0.98%
Net Income Q/Q Growth
1.73% 5.79% 0.47% 8.22% -50.63% 108.22% -56.55% 171.33% 5.63% -1.17%
EPS Q/Q Growth
1.79% 5.60% 0.96% 7.52% -2.17% 4.05% -56.94% 170.75% 5.35% -1.07%
Operating Cash Flow Q/Q Growth
-0.71% 1.85% 11.42% 0.33% -2.14% 8.50% 319.61% -197.81% 6.67% -6.77%
Free Cash Flow Firm Q/Q Growth
10.94% 8.99% 270.31% -148.32% 192.67% 222.71% -1,358.48% -14.64% 20.59% 11.45%
Invested Capital Q/Q Growth
-7.87% -6.97% -6.67% 9.11% -20.09% -3.84% 14.64% 5.96% -6.24% -4.95%
Profitability Metrics
- - - - - - - - - -
Gross Margin
86.13% 85.15% 85.00% 82.15% 82.46% 81.54% 81.68% 84.53% 84.89% 79.64%
EBITDA Margin
9.94% -16.25% 30.20% 71.93% 61.01% 51.89% 53.05% 60.11% 66.32% 65.31%
Operating Margin
64.13% 61.58% 60.08% 56.40% 54.01% 53.16% 60.51% 63.40% 61.21% 59.78%
EBIT Margin
4.44% -22.57% 22.98% 63.71% 51.50% 42.17% 47.28% 54.39% 60.06% 58.44%
Profit (Net Income) Margin
57.52% 57.83% 53.61% 56.23% 43.13% 86.93% 45.53% 111.49% 42.67% 37.48%
Tax Burden Percent
77.64% 77.67% 77.10% 78.16% 77.38% 157.33% 70.64% 160.84% 67.06% 63.73%
Interest Burden Percent
1,667.79% -329.86% 302.58% 112.91% 108.23% 131.01% 136.33% 127.44% 105.95% 100.65%
Effective Tax Rate
22.36% 22.33% 22.90% 21.84% 22.62% 21.33% 29.31% -60.84% 32.94% 36.27%
Return on Invested Capital (ROIC)
11.29% 9.77% 8.40% 8.09% 7.93% 7.12% 7.15% 17.18% 7.09% 5.95%
ROIC Less NNEP Spread (ROIC-NNEP)
126.21% 118.68% 73.86% -34.71% -4.59% 93.88% 14.59% 150.95% 22.80% 2.36%
Return on Net Nonoperating Assets (RNNOA)
1.95% 2.27% 1.52% 1.72% 0.09% 9.12% 0.96% 1.83% 0.41% 0.06%
Return on Equity (ROE)
13.25% 12.03% 9.92% 9.81% 8.02% 16.24% 8.11% 19.01% 7.50% 6.01%
Cash Return on Invested Capital (CROIC)
12.15% 11.09% 9.82% -10.30% 27.64% 9.40% -17.16% 7.79% 8.99% 8.65%
Operating Return on Assets (OROA)
0.20% -0.83% 0.62% 1.86% 2.52% 2.69% 2.66% 2.73% 3.16% 2.79%
Return on Assets (ROA)
2.64% 2.12% 1.45% 1.64% 2.11% 5.54% 2.56% 5.60% 2.24% 1.79%
Return on Common Equity (ROCE)
13.25% 12.03% 9.92% 9.81% 8.01% 16.21% 8.10% 19.01% 7.50% 6.01%
Return on Equity Simple (ROE_SIMPLE)
13.31% 12.07% 10.01% 9.62% 8.00% 16.20% 7.57% 18.13% 7.54% 6.07%
Net Operating Profit after Tax (NOPAT)
3,052 2,669 2,325 2,068 2,041 2,036 1,843 3,716 1,476 1,267
NOPAT Margin
49.79% 47.83% 46.33% 44.09% 41.79% 41.82% 42.78% 101.97% 41.05% 38.09%
Net Nonoperating Expense Percent (NNEP)
-114.92% -108.91% -65.46% 42.80% 12.52% -86.76% -7.44% -133.77% -15.71% 3.59%
Return On Investment Capital (ROIC_SIMPLE)
10.20% 8.85% 7.67% - - - - - - -
Cost of Revenue to Revenue
13.87% 14.85% 15.00% 17.85% 17.54% 18.46% 18.32% 15.47% 15.11% 20.36%
SG&A Expenses to Revenue
6.53% 7.54% 7.55% 8.37% 9.87% 10.98% 11.44% 8.61% 10.93% 7.43%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
21.99% 23.56% 24.91% 25.75% 28.46% 28.38% 21.17% 21.13% 23.68% 19.86%
Earnings before Interest and Taxes (EBIT)
272 -1,259 1,154 2,988 2,515 2,053 2,038 1,982 2,159 1,944
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
609 -907 1,516 3,373 2,979 2,526 2,286 2,191 2,384 2,173
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
3.16 2.71 2.05 2.70 2.17 2.33 2.03 1.78 1.48 1.09
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
13.65 12.98 10.98 15.76 11.68 12.49 12.23 10.93 8.35 6.71
Price to Earnings (P/E)
24.04 22.74 20.74 28.25 27.09 14.36 26.89 9.80 19.57 17.91
Dividend Yield
4.48% 4.80% 5.55% 3.33% 3.71% 3.24% 2.94% 5.25% 6.39% 7.42%
Earnings Yield
4.16% 4.40% 4.82% 3.54% 3.69% 6.96% 3.72% 10.20% 5.11% 5.58%
Enterprise Value to Invested Capital (EV/IC)
3.13 2.68 2.03 2.67 2.53 2.23 1.93 1.77 1.47 1.09
Enterprise Value to Revenue (EV/Rev)
13.72 13.06 11.11 15.87 12.04 12.93 12.93 11.00 8.43 6.85
Enterprise Value to EBITDA (EV/EBITDA)
138.09 0.00 36.77 22.06 19.73 24.91 24.37 18.29 12.71 10.50
Enterprise Value to EBIT (EV/EBIT)
308.88 0.00 48.33 24.91 23.37 30.66 27.35 20.22 14.03 11.73
Enterprise Value to NOPAT (EV/NOPAT)
27.56 27.30 23.97 36.00 28.80 30.91 30.23 10.78 20.53 17.99
Enterprise Value to Operating Cash Flow (EV/OCF)
22.79 21.09 18.24 30.98 21.64 23.55 22.83 0.00 17.49 14.88
Enterprise Value to Free Cash Flow (EV/FCFF)
25.62 24.04 20.50 0.00 8.26 23.42 0.00 23.78 16.19 12.38
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.13 0.13 0.13 0.13 0.13 0.14 0.17 0.10 0.11 0.11
Long-Term Debt to Equity
0.10 0.13 0.13 0.10 0.13 0.14 0.15 0.10 0.11 0.11
Financial Leverage
0.02 0.02 0.02 -0.05 -0.02 0.10 0.07 0.01 0.02 0.03
Leverage Ratio
5.02 5.67 6.83 5.98 3.81 2.93 3.17 3.40 3.34 3.37
Compound Leverage Factor
83.71 -18.70 20.68 6.75 4.12 3.84 4.32 4.33 3.54 3.39
Debt to Total Capital
11.46% 11.36% 11.34% 11.17% 11.56% 12.52% 14.49% 9.06% 9.88% 9.79%
Short-Term Debt to Total Capital
2.51% 0.00% 0.05% 2.43% 0.00% 0.00% 1.89% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
8.95% 11.36% 11.29% 8.74% 11.56% 12.52% 12.60% 9.06% 9.88% 9.79%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.11% 0.10% 0.15% 0.00% 0.00% 0.00%
Common Equity to Total Capital
88.54% 88.64% 88.66% 88.83% 88.34% 87.38% 85.35% 90.94% 90.12% 90.21%
Debt to EBITDA
5.63 -3.78 2.27 1.02 1.16 1.48 1.92 1.02 0.94 1.03
Net Debt to EBITDA
0.69 -0.44 0.41 0.15 0.57 0.83 1.29 0.11 0.12 0.21
Long-Term Debt to EBITDA
4.40 -3.78 2.26 0.80 1.16 1.48 1.67 1.02 0.94 1.03
Debt to NOPAT
1.12 1.28 1.48 1.67 1.69 1.84 2.39 0.60 1.51 1.76
Net Debt to NOPAT
0.14 0.15 0.27 0.24 0.84 1.04 1.60 0.06 0.19 0.37
Long-Term Debt to NOPAT
0.88 1.28 1.47 1.30 1.69 1.84 2.08 0.60 1.51 1.76
Altman Z-Score
0.55 0.49 0.32 0.38 0.52 1.01 0.85 0.68 0.59 0.51
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.06% 0.12% 0.15% 0.10% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.01 1.02 1.01 1.01 1.01 1.03 1.01 1.03 1.03 1.03
Quick Ratio
0.04 0.04 0.02 0.02 0.02 0.06 0.05 0.05 0.06 0.06
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
3,283 3,030 2,719 -2,631 7,113 2,687 -4,424 1,685 1,872 1,842
Operating Cash Flow to CapEx
3,926.06% 4,520.68% 3,406.91% 2,733.11% 1,374.99% 1,088.27% 2,091.52% -2,138.10% 1,886.71% 1,341.94%
Free Cash Flow to Firm to Interest Expense
20.40 19.01 16.71 -15.76 42.80 15.09 -28.06 14.40 15.16 15.69
Operating Cash Flow to Interest Expense
22.94 21.67 18.78 14.39 16.34 15.02 15.48 -14.97 14.02 13.05
Operating Cash Flow Less CapEx to Interest Expense
22.35 21.19 18.23 13.87 15.15 13.64 14.74 -15.67 13.28 12.08
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.05 0.04 0.03 0.03 0.05 0.06 0.06 0.05 0.05 0.05
Accounts Receivable Turnover
11.06 10.95 10.94 10.47 10.25 9.32 9.44 10.07 9.96 9.52
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
15.41 12.90 10.45 8.65 8.70 9.81 10.16 8.84 7.84 6.65
Accounts Payable Turnover
9.97 7.82 8.85 14.17 13.06 10.10 10.72 19.61 19.79 20.66
Days Sales Outstanding (DSO)
33.01 33.33 33.37 34.86 35.62 39.18 38.66 36.26 36.66 38.35
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
36.59 46.69 41.24 25.75 27.96 36.13 34.05 18.61 18.44 17.67
Cash Conversion Cycle (CCC)
-3.59 -13.37 -7.88 9.11 7.66 3.05 4.61 17.65 18.22 20.67
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
26,909 27,140 27,501 27,895 23,196 28,268 28,919 22,651 20,620 21,016
Invested Capital Turnover
0.23 0.20 0.18 0.18 0.19 0.17 0.17 0.17 0.17 0.16
Increase / (Decrease) in Invested Capital
-230 -361 -394 4,699 -5,072 -651 6,268 2,031 -396 -575
Enterprise Value (EV)
84,109 72,839 55,743 74,425 58,779 62,933 55,724 40,075 30,296 22,802
Market Capitalization
83,687 72,438 55,121 73,930 57,037 60,794 52,724 39,836 30,016 22,338
Book Value per Share
$73.50 $74.27 $74.72 $76.24 $73.32 $72.91 $76.05 $65.86 $59.94 $60.76
Tangible Book Value per Share
($11.09) ($11.06) ($11.26) ($10.67) ($4.61) ($19.27) ($22.19) ($13.75) ($20.17) ($19.90)
Total Capital
29,915 30,163 30,317 30,844 29,795 29,903 30,366 24,645 22,572 22,781
Total Debt
3,428 3,425 3,438 3,445 3,444 3,743 4,401 2,233 2,231 2,229
Total Long-Term Debt
2,678 3,425 3,422 2,696 3,444 3,743 3,827 2,233 2,231 2,229
Net Debt
422 402 622 495 1,710 2,109 2,954 239 279 464
Capital Expenditures (CapEx)
94 76 90 88 198 246 117 82 92 114
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-1,536 -1,550 -1,409 -837 -648 -589 -259 -760 -866 -685
Debt-free Net Working Capital (DFNWC)
1,469 1,473 1,407 2,113 1,086 1,045 1,188 1,234 1,086 1,080
Net Working Capital (NWC)
720 1,473 1,391 1,363 1,086 1,045 614 1,234 1,086 1,080
Net Nonoperating Expense (NNE)
-474 -558 -366 -569 -66 -2,196 -119 -347 -58 20
Net Nonoperating Obligations (NNO)
422 402 622 495 -3,156 2,109 2,954 239 279 464
Total Depreciation and Amortization (D&A)
337 353 363 385 464 473 249 209 225 229
Debt-free, Cash-free Net Working Capital to Revenue
-25.06% -27.79% -28.08% -17.85% -13.27% -12.11% -6.01% -20.85% -24.09% -20.59%
Debt-free Net Working Capital to Revenue
23.97% 26.41% 28.03% 45.05% 22.24% 21.47% 27.57% 33.85% 30.20% 32.46%
Net Working Capital to Revenue
11.74% 26.41% 27.71% 29.07% 22.24% 21.47% 14.25% 33.85% 30.20% 32.46%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$9.69 $8.87 $7.41 $7.30 $5.88 $5.93 $5.73 $12.00 $4.55 $3.71
Adjusted Weighted Average Basic Shares Outstanding
359.39M 359.02M 358.71M 358.34M 357.76M 357.16M 342.34M 338.71M 337.50M 336.22M
Adjusted Diluted Earnings per Share
$9.67 $8.86 $7.40 $7.29 $5.87 $5.91 $5.71 $11.94 $4.53 $3.69
Adjusted Weighted Average Diluted Shares Outstanding
359.94M 359.50M 359.18M 358.93M 358.52M 358.24M 343.74M 340.23M 338.97M 337.89M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
360.36M 359.99M 359.72M 359.40M 359.01M 358.41M 357.80M 340.39M 339.65M 338.42M
Normalized Net Operating Profit after Tax (NOPAT)
3,052 2,669 2,325 2,068 2,041 2,036 1,843 1,617 1,476 1,267
Normalized NOPAT Margin
49.79% 47.83% 46.33% 44.09% 41.79% 41.82% 42.78% 44.38% 41.05% 38.09%
Pre Tax Income Margin
74.08% 74.45% 69.54% 71.94% 55.74% 55.25% 64.46% 69.31% 63.63% 58.82%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
1.69 -7.90 7.09 17.90 15.13 11.53 12.92 16.94 17.48 16.56
NOPAT to Interest Expense
18.97 16.74 14.29 12.39 12.28 11.44 11.69 31.76 11.95 10.80
EBIT Less CapEx to Interest Expense
1.11 -8.38 6.54 17.38 13.94 10.15 12.18 16.24 16.74 15.59
NOPAT Less CapEx to Interest Expense
18.39 16.26 13.74 11.86 11.09 10.06 10.95 31.06 11.21 9.82
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
101.66% 100.29% 97.86% 83.03% 100.17% 40.08% 109.57% 49.06% 116.50% 107.73%
Augmented Payout Ratio
101.66% 100.29% 97.86% 83.03% 100.17% 40.08% 109.57% 49.06% 116.50% 107.73%

Quarterly Metrics And Ratios for CME Group

This table displays calculated financial ratios and metrics derived from CME Group's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
10.38% 5.98% 18.43% 12.67% 3.21% 19.17% 8.96% 9.94% 7.05% 5.27% 10.62%
EBITDA Growth
384.52% 1,749.57% 176.12% 129.73% 153.26% 95.47% -199.76% -179.90% -116.63% -132.28% -75.76%
EBIT Growth
5,976.92% 211.84% 131.07% 110.86% 97.83% 71.92% -312.68% -210.20% -129.43% -149.44% -82.96%
NOPAT Growth
15.47% 8.07% 25.78% 19.31% 5.60% 35.64% 10.69% 11.95% 4.71% 4.29% 9.99%
Net Income Growth
11.81% 7.37% 21.67% 13.58% -3.24% 27.70% 10.39% 17.37% 24.30% 2.03% -26.63%
EPS Growth
11.49% 7.62% 21.36% 13.08% -3.29% 26.70% 10.16% 17.58% 24.62% 4.14% -27.52%
Operating Cash Flow Growth
25.08% -2.53% 17.08% 19.45% -1.07% 6.40% 30.24% 5.31% 12.93% 46.87% 4.15%
Free Cash Flow Firm Growth
8.54% -7.05% -18.17% 134.34% 129.94% 16.68% 127.78% -90.72% -199.99% 121.62% -183.63%
Invested Capital Growth
-0.31% -0.85% 0.13% -0.36% -0.45% -1.31% -1.00% 12.17% 14.08% -1.41% 15.26%
Revenue Q/Q Growth
7.67% -3.73% 3.39% 3.00% 3.38% 7.59% -1.65% -5.65% 19.36% -1.63% -0.76%
EBITDA Q/Q Growth
101.09% 2.61% 27.18% 84.64% 784.62% 95.27% 50.32% -230.72% 41.80% -204.32% -60.21%
EBIT Q/Q Growth
178.83% 5.18% 63.58% 1,325.00% 94.69% 70.78% 42.83% -145.38% 31.49% -321.31% -70.38%
NOPAT Q/Q Growth
12.68% -4.91% 3.78% 3.85% 5.45% 10.68% -1.56% -8.09% 35.46% -9.68% -0.44%
Net Income Q/Q Growth
9.33% -4.18% 3.35% 3.27% 4.98% 8.58% -3.52% -12.02% 38.55% -6.14% 2.58%
EPS Q/Q Growth
9.17% -4.00% 3.31% 2.98% 5.38% 8.25% -3.74% -11.93% 38.07% -5.88% 2.75%
Operating Cash Flow Q/Q Growth
9.70% 1.49% 29.10% -12.97% -14.52% 21.90% 31.72% -27.93% -8.06% 49.21% 6.51%
Free Cash Flow Firm Q/Q Growth
-4.38% 30.18% -12.91% 0.12% -18.11% 14.60% 136.55% 12.71% -419.12% 127.29% -150.91%
Invested Capital Q/Q Growth
7.51% -7.87% 0.20% 0.44% 6.94% -6.97% -0.28% 0.35% 6.01% -6.67% 12.97%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
87.41% 85.52% 86.19% 86.64% 86.16% 85.21% 84.64% 84.88% 85.81% 84.02% 84.56%
EBITDA Margin
23.63% 12.65% 11.87% 9.65% 5.38% -0.81% -18.47% -36.57% -10.43% -21.39% 20.17%
Operating Margin
67.47% 62.09% 64.64% 65.29% 64.49% 59.97% 61.31% 61.65% 63.38% 55.33% 60.17%
EBIT Margin
18.61% 7.19% 6.58% 4.16% -0.35% -6.81% -25.07% -43.13% -16.59% -28.90% 12.84%
Profit (Net Income) Margin
58.22% 57.34% 57.61% 57.63% 57.48% 56.60% 56.08% 57.17% 61.31% 52.82% 55.35%
Tax Burden Percent
76.82% 79.76% 77.56% 76.50% 76.81% 80.97% 77.00% 76.51% 76.39% 77.11% 77.23%
Interest Burden Percent
407.33% 1,000.55% 1,129.46% 1,812.40% -21,411.54% -1,026.53% -290.49% -173.24% -483.86% -237.05% 558.02%
Effective Tax Rate
23.18% 20.24% 22.44% 23.50% 23.19% 19.03% 23.00% 23.49% 23.61% 22.89% 22.77%
Return on Invested Capital (ROIC)
11.24% 11.23% 10.38% 9.92% 9.58% 9.92% 8.61% 8.93% 9.05% 7.73% 8.38%
ROIC Less NNEP Spread (ROIC-NNEP)
16.82% 40.17% 22.15% 17.89% 16.08% 32.50% 19.23% -47.40% -81.09% 29.67% -35.03%
Return on Net Nonoperating Assets (RNNOA)
1.17% 0.62% 0.79% 0.95% 1.07% 0.62% 0.76% 0.41% 0.61% 0.61% 0.32%
Return on Equity (ROE)
12.41% 11.86% 11.17% 10.87% 10.65% 10.54% 9.37% 9.34% 9.66% 8.34% 8.69%
Cash Return on Invested Capital (CROIC)
11.24% 12.15% 10.14% 10.06% 9.76% 11.09% 9.48% -2.70% -4.54% 9.82% -5.80%
Operating Return on Assets (OROA)
0.81% 0.33% 0.30% 0.18% -0.01% -0.25% -0.88% -1.38% -0.46% -0.78% 0.35%
Return on Assets (ROA)
2.52% 2.63% 2.64% 2.43% 2.17% 2.08% 1.97% 1.83% 1.69% 1.43% 1.50%
Return on Common Equity (ROCE)
12.41% 11.86% 11.17% 10.87% 10.65% 10.54% 9.37% 9.34% 9.66% 8.34% 8.69%
Return on Equity Simple (ROE_SIMPLE)
13.42% 0.00% 12.28% 11.95% 11.78% 0.00% 10.83% 10.71% 10.46% 0.00% 9.48%
Net Operating Profit after Tax (NOPAT)
851 755 794 765 737 699 632 642 698 515 571
NOPAT Margin
51.82% 49.52% 50.14% 49.95% 49.54% 48.56% 47.21% 47.17% 48.42% 42.66% 46.47%
Net Nonoperating Expense Percent (NNEP)
-5.58% -28.94% -11.76% -7.98% -6.50% -22.58% -10.62% 56.33% 90.15% -21.94% 43.40%
Return On Investment Capital (ROIC_SIMPLE)
2.80% 2.53% - - - 2.32% - - - 1.70% -
Cost of Revenue to Revenue
12.59% 14.48% 13.81% 13.36% 13.85% 14.79% 15.36% 15.12% 14.19% 15.98% 15.44%
SG&A Expenses to Revenue
5.04% 8.15% 5.89% 6.07% 6.03% 9.59% 6.63% 6.99% 6.85% 11.05% 6.43%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
19.95% 23.43% 21.55% 21.35% 21.66% 25.23% 23.33% 23.22% 22.43% 28.69% 24.39%
Earnings before Interest and Taxes (EBIT)
306 110 104 64 -5.20 -98 -335 -587 -239 -349 158
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
388 193 188 148 80 -12 -247 -497 -150 -258 248
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.54 3.16 2.82 2.56 2.84 2.71 2.44 2.29 2.39 2.05 2.06
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
15.21 13.65 13.15 12.21 13.70 12.98 12.86 12.15 12.78 10.98 11.73
Price to Earnings (P/E)
26.69 24.04 23.20 21.70 24.41 22.74 22.81 21.61 23.10 20.74 21.87
Dividend Yield
3.96% 4.48% 4.44% 4.96% 4.53% 4.80% 4.60% 4.92% 4.73% 5.55% 4.42%
Earnings Yield
3.75% 4.16% 4.31% 4.61% 4.10% 4.40% 4.38% 4.63% 4.33% 4.82% 4.57%
Enterprise Value to Invested Capital (EV/IC)
3.37 3.13 2.75 2.48 2.72 2.68 2.39 2.22 2.30 2.03 2.02
Enterprise Value to Revenue (EV/Rev)
15.51 13.72 13.31 12.47 14.03 13.06 13.05 12.43 13.13 11.11 11.97
Enterprise Value to EBITDA (EV/EBITDA)
106.31 138.09 198.93 0.00 0.00 0.00 0.00 0.00 145.54 36.77 23.06
Enterprise Value to EBIT (EV/EBIT)
167.21 308.88 1,243.41 0.00 0.00 0.00 0.00 0.00 658.34 48.33 26.89
Enterprise Value to NOPAT (EV/NOPAT)
30.79 27.56 26.85 25.52 29.14 27.30 28.08 26.83 28.49 23.97 25.76
Enterprise Value to Operating Cash Flow (EV/OCF)
24.91 22.79 21.64 20.25 22.92 21.09 20.59 20.39 21.25 18.24 21.65
Enterprise Value to Free Cash Flow (EV/FCFF)
29.93 25.62 27.19 24.62 27.79 24.04 25.11 0.00 0.00 20.50 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.13 0.13 0.12 0.12 0.13 0.13 0.12 0.12 0.13 0.13 0.12
Long-Term Debt to Equity
0.13 0.10 0.09 0.10 0.10 0.13 0.12 0.12 0.13 0.13 0.12
Financial Leverage
0.07 0.02 0.04 0.05 0.07 0.02 0.04 -0.01 -0.01 0.02 -0.01
Leverage Ratio
5.35 5.02 4.67 4.95 5.47 5.67 5.39 5.88 6.75 6.83 6.58
Compound Leverage Factor
21.79 50.22 52.78 89.77 -1,170.30 -58.18 -15.66 -10.18 -32.65 -16.20 36.70
Debt to Total Capital
11.23% 11.46% 10.83% 11.03% 11.20% 11.36% 10.85% 10.96% 11.16% 11.34% 10.84%
Short-Term Debt to Total Capital
0.00% 2.51% 2.37% 2.41% 2.45% 0.00% 0.00% 0.00% 0.05% 0.05% 0.05%
Long-Term Debt to Total Capital
11.23% 8.95% 8.46% 8.62% 8.75% 11.36% 10.85% 10.96% 11.11% 11.29% 10.80%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
88.77% 88.54% 89.17% 88.97% 88.80% 88.64% 89.15% 89.04% 88.84% 88.66% 89.16%
Debt to EBITDA
3.73 5.63 8.48 -111.26 -5.07 -3.78 -2.97 -5.20 7.45 2.27 1.33
Net Debt to EBITDA
2.07 0.69 2.46 -49.19 -2.76 -0.44 -0.88 -2.18 3.83 0.41 0.47
Long-Term Debt to EBITDA
3.73 4.40 6.62 -86.92 -3.96 -3.78 -2.97 -5.20 7.42 2.26 1.33
Debt to NOPAT
1.08 1.12 1.14 1.21 1.26 1.28 1.38 1.41 1.46 1.48 1.49
Net Debt to NOPAT
0.60 0.14 0.33 0.53 0.69 0.15 0.41 0.59 0.75 0.27 0.53
Long-Term Debt to NOPAT
1.08 0.88 0.89 0.95 0.99 1.28 1.38 1.41 1.45 1.47 1.48
Altman Z-Score
0.54 0.55 0.56 0.57 0.55 0.52 0.55 0.40 0.37 0.29 0.33
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.02 1.01 1.02 1.02 1.01 1.02 1.03 1.02 1.02 1.01 1.02
Quick Ratio
0.02 0.04 0.03 0.03 0.02 0.04 0.03 0.02 0.02 0.02 0.02
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
943 986 757 869 868 1,060 925 -2,532 -2,900 909 -3,330
Operating Cash Flow to CapEx
7,863.38% 3,885.11% 3,365.77% 4,268.68% 4,508.59% 5,020.67% 4,305.03% 3,172.68% 5,936.84% 4,022.54% 2,740.83%
Free Cash Flow to Firm to Interest Expense
22.60 24.22 18.84 21.68 21.76 26.71 23.36 -62.97 -72.69 22.78 -82.44
Operating Cash Flow to Interest Expense
26.78 25.01 24.95 19.37 22.37 26.30 21.63 16.18 22.62 24.60 16.28
Operating Cash Flow Less CapEx to Interest Expense
26.44 24.37 24.21 18.92 21.88 25.78 21.13 15.67 22.24 23.99 15.69
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.04 0.05 0.05 0.04 0.04 0.04 0.04 0.03 0.03 0.03 0.03
Accounts Receivable Turnover
8.99 11.06 10.18 9.67 8.32 10.95 9.39 8.86 7.68 10.94 9.44
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
16.38 15.41 15.04 14.23 13.45 12.90 12.11 11.49 10.95 10.45 10.05
Accounts Payable Turnover
8.06 9.97 9.17 11.00 7.97 7.82 10.87 12.03 8.68 8.85 9.18
Days Sales Outstanding (DSO)
40.61 33.01 35.87 37.74 43.86 33.33 38.86 41.18 47.55 33.37 38.66
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
45.29 36.59 39.80 33.19 45.77 46.69 33.58 30.34 42.06 41.24 39.77
Cash Conversion Cycle (CCC)
-4.68 -3.59 -3.93 4.55 -1.92 -13.37 5.28 10.84 5.49 -7.88 -1.10
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
28,931 26,909 29,209 29,151 29,022 27,140 29,172 29,255 29,154 27,501 29,466
Invested Capital Turnover
0.22 0.23 0.21 0.20 0.19 0.20 0.18 0.19 0.19 0.18 0.18
Increase / (Decrease) in Invested Capital
-91 -230 37 -104 -131 -361 -294 3,173 3,598 -394 3,901
Enterprise Value (EV)
97,499 84,109 80,448 72,304 78,929 72,839 69,805 65,075 67,151 55,743 59,379
Market Capitalization
95,599 83,687 79,455 70,789 77,061 72,438 68,784 63,638 65,382 55,121 58,164
Book Value per Share
$75.01 $73.50 $78.36 $76.75 $75.58 $74.27 $78.25 $77.33 $76.13 $74.72 $78.60
Tangible Book Value per Share
($9.48) ($11.09) ($6.57) ($8.22) ($9.74) ($11.06) ($7.22) ($8.36) ($9.73) ($11.26) ($7.44)
Total Capital
30,450 29,915 31,644 31,063 30,580 30,163 31,576 31,242 30,824 30,317 31,687
Total Debt
3,419 3,428 3,427 3,427 3,426 3,425 3,425 3,424 3,439 3,438 3,436
Total Long-Term Debt
3,419 2,678 2,678 2,677 2,677 3,425 3,425 3,424 3,423 3,422 3,422
Net Debt
1,900 422 993 1,515 1,868 402 1,020 1,437 1,769 622 1,215
Capital Expenditures (CapEx)
14 26 30 18 20 21 20 21 15 24 24
Debt-free, Cash-free Net Working Capital (DFCFNWC)
506 -1,536 636 613 398 -1,550 492 494 334 -1,409 473
Debt-free Net Working Capital (DFNWC)
2,025 1,469 3,071 2,524 1,956 1,473 2,896 2,480 2,004 1,407 2,695
Net Working Capital (NWC)
2,025 720 2,321 1,775 1,206 1,473 2,896 2,480 1,988 1,391 2,680
Net Nonoperating Expense (NNE)
-105 -119 -118 -118 -118 -116 -119 -136 -186 -123 -109
Net Nonoperating Obligations (NNO)
1,900 422 993 1,515 1,868 402 1,020 1,437 1,769 622 1,215
Total Depreciation and Amortization (D&A)
83 83 84 84 85 86 88 89 89 91 90
Debt-free, Cash-free Net Working Capital to Revenue
8.05% -25.06% 10.53% 10.56% 7.07% -27.79% 9.20% 9.42% 6.53% -28.08% 9.54%
Debt-free Net Working Capital to Revenue
32.23% 23.97% 50.80% 43.54% 34.77% 26.41% 54.16% 47.36% 39.19% 28.03% 54.34%
Net Working Capital to Revenue
32.23% 11.74% 38.40% 30.61% 21.44% 26.41% 54.16% 47.36% 38.87% 27.71% 54.05%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.63 $2.40 $2.51 $2.43 $2.35 $2.24 $2.06 $2.14 $2.43 $1.76 $1.87
Adjusted Weighted Average Basic Shares Outstanding
359.61M 359.39M 359.40M 359.33M 359.26M 359.02M 359.02M 358.94M 358.93M 358.71M 358.72M
Adjusted Diluted Earnings per Share
$2.62 $2.40 $2.50 $2.42 $2.35 $2.23 $2.06 $2.14 $2.43 $1.76 $1.87
Adjusted Weighted Average Diluted Shares Outstanding
360.23M 359.94M 359.99M 359.87M 359.83M 359.50M 359.62M 359.43M 359.31M 359.18M 359.29M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
360.36M 360.36M 360.36M 720.19M 720.13M 359.99M 719.99M 719.50M 359.72M 359.72M 359.73M
Normalized Net Operating Profit after Tax (NOPAT)
851 755 794 765 737 699 632 642 698 515 571
Normalized NOPAT Margin
51.82% 49.52% 50.14% 49.95% 49.54% 48.56% 47.21% 47.17% 48.42% 42.66% 46.47%
Pre Tax Income Margin
75.80% 71.89% 74.28% 75.33% 74.83% 69.90% 72.83% 74.72% 80.25% 68.50% 71.67%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
7.33 2.69 2.59 1.59 -0.13 -2.47 -8.47 -14.59 -5.99 -8.75 3.90
NOPAT to Interest Expense
20.41 18.56 19.76 19.09 18.47 17.61 15.95 15.96 17.49 12.91 14.12
EBIT Less CapEx to Interest Expense
6.99 2.05 1.85 1.13 -0.63 -2.99 -8.97 -15.10 -6.37 -9.36 3.31
NOPAT Less CapEx to Interest Expense
20.07 17.92 19.02 18.64 17.98 17.08 15.45 15.45 17.11 12.30 13.53
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
105.42% 101.66% 102.88% 107.38% 110.34% 100.29% 104.90% 106.15% 109.14% 97.86% 96.96%
Augmented Payout Ratio
105.42% 101.66% 102.88% 107.38% 110.34% 100.29% 104.90% 106.15% 109.14% 97.86% 96.96%

Frequently Asked Questions About CME Group's Financials

When does CME Group's financial year end?

According to the most recent income statement we have on file, CME Group's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has CME Group's net income changed over the last 9 years?

CME Group's net income appears to be on an upward trend, with a most recent value of $3.53 billion in 2024, rising from $1.25 billion in 2015. The previous period was $3.23 billion in 2023. Check out CME Group's forecast to explore projected trends and price targets.

What is CME Group's operating income?
CME Group's total operating income in 2024 was $3.93 billion, based on the following breakdown:
  • Total Gross Profit: $5.28 billion
  • Total Operating Expenses: $1.35 billion
How has CME Group revenue changed over the last 9 years?

Over the last 9 years, CME Group's total revenue changed from $3.33 billion in 2015 to $6.13 billion in 2024, a change of 84.3%.

How much debt does CME Group have?

CME Group's total liabilities were at $110.96 billion at the end of 2024, a 7.8% increase from 2023, and a 137.1% increase since 2015.

How much cash does CME Group have?

In the past 9 years, CME Group's cash and equivalents has ranged from $1.37 billion in 2018 to $2.91 billion in 2023, and is currently $2.89 billion as of their latest financial filing in 2024.

How has CME Group's book value per share changed over the last 9 years?

Over the last 9 years, CME Group's book value per share changed from 60.76 in 2015 to 73.50 in 2024, a change of 21.0%.



This page (NASDAQ:CME) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners